Accelerate Dx 2013 Revenues Down 8 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics said in a document filed with the US Securities and Exchange Commission on Friday that revenues for 2013 were down 8 percent year over year.

The Tucson, Ariz.-based company did not break out revenues for the fourth quarter but based on previously disclosed financial figures for the first three quarters of the year, revenues for Q4 2013 were down 18 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Sponsored by

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit. 

Sponsored by

This webinar will focus on a range of research and clinical applications enabled by improvements in mate pair technology for whole genome sequencing. 

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.